Reduced Endothelial Progenitor Cells: A Possible Biomarker for Idiopathic Fetal Growth Restriction in Human Pregnancies

1. Armengaud JB, Yzydorczyk C, Siddeek B, Peyter AC, Simeoni U. Intrauterine growth restriction: Clinical consequences on health and disease at adulthood. Reprod Toxicol. 2021 Jan;99:168–176. doi: 10.1016/j.reprotox.2020.10.005 ArmengaudJB YzydorczykC SiddeekB PeyterAC SimeoniU Intrauterine growth restriction: Clinical consequences on health and disease at adulthood Reprod Toxicol 2021 Jan 99 168 176 10.1016/j.reprotox.2020.10.005 Open DOISearch in Google Scholar

2. Sharma D, Shastri S, Farahbakhsh N, Sharma P. Intrauterine growth restriction - part 1. J Matern Fetal Neonatal Med. 2016 Dec;29(24):3977–87. doi: 10.3109/14767058.2016.1152249 SharmaD ShastriS FarahbakhshN SharmaP Intrauterine growth restriction - part 1 J Matern Fetal Neonatal Med 2016 Dec 29 24 3977 87 10.3109/14767058.2016.1152249 Open DOISearch in Google Scholar

3. Blann AD, Woywodt A, Bertolini F, Bull TM, Buyon JP, Clancy RM, et al. Circulating endothelial cells. Biomarker of vascular disease. Thromb Haemost. 2005 Feb;93(2):228–35. doi: 10.1160/TH04-09-0578 BlannAD WoywodtA BertoliniF BullTM BuyonJP ClancyRM Circulating endothelial cells. Biomarker of vascular disease Thromb Haemost 2005 Feb 93 2 228 35 10.1160/TH04-09-0578 Open DOISearch in Google Scholar

4. Suparman E, Mose JC, Handono B, Khairini AF. The Difference in Endothelial Progenitor Cells (Epcs Cd34), Clotting Factors, Blood Pressure and Proteinuria among Preeclampsia Model Mice with and without the Administration of Epcs Cd34. Ann Rom Soc Cell Biol. 2021 May 5;25(5):1760–79. Available from: https://www.annalsofrscb.ro/index.php/journal/article/view/4699 SuparmanE MoseJC HandonoB KhairiniAF The Difference in Endothelial Progenitor Cells (Epcs Cd34), Clotting Factors, Blood Pressure and Proteinuria among Preeclampsia Model Mice with and without the Administration of Epcs Cd34 Ann Rom Soc Cell Biol. 2021 May 5 25 5 1760 79 Available from: https://www.annalsofrscb.ro/index.php/journal/article/view/4699 Search in Google Scholar

5. Asahara T, Masuda H, Takahashi T, Kalka C, Pastore C, Silver M, et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res. 1999 Aug 6;85(3):221–8. doi: 10.1161/01.res.85.3.221 AsaharaT MasudaH TakahashiT KalkaC PastoreC SilverM Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization Circ Res. 1999 Aug 6 85 3 221 8 10.1161/01.res.85.3.221 Open DOISearch in Google Scholar

6. Strehlow K, Werner N, Berweiler J, Link A, Dirnagl U, Priller J, et al. Estrogen increases bone marrow-derived endothelial progenitor cell production and diminishes neointima formation. Circulation. 2003 Jun 24;107(24):3059–65. doi: 10.1161/01.CIR.0000077911.81151.30 StrehlowK WernerN BerweilerJ LinkA DirnaglU PrillerJ Estrogen increases bone marrow-derived endothelial progenitor cell production and diminishes neointima formation Circulation. 2003 Jun 24 107 24 3059 65 10.1161/01.CIR.0000077911.81151.30 Open DOISearch in Google Scholar

7. Patschan S, Tampe D, Müller C, Seitz C, Herink C, Müller GA, et al. Early Endothelial Progenitor Cells (eEPCs) in systemic sclerosis (SSc) - dynamics of cellular regeneration and mesenchymal transdifferentiation. BMC Musculoskelet Disord. 2016 Aug 12;17:339. doi: 10.1186/s12891-016-1197-2 PatschanS TampeD MüllerC SeitzC HerinkC MüllerGA Early Endothelial Progenitor Cells (eEPCs) in systemic sclerosis (SSc) - dynamics of cellular regeneration and mesenchymal transdifferentiation BMC Musculoskelet Disord. 2016 Aug 12 17 339 10.1186/s12891-016-1197-2 Open DOISearch in Google Scholar

8. Luppi P, Powers RW, Verma V, Edmunds L, Plymire D, Hubel CA. Maternal circulating CD34⁺VEGFR-2⁺ and CD133⁺VEGFR-2⁺ progenitor cells increase during normal pregnancy but are reduced in women with preeclampsia. Reprod Sci. 2010 Jul;17(7):643–52. doi: 10.1177/1933719110366164 LuppiP PowersRW VermaV EdmundsL PlymireD HubelCA Maternal circulating CD34⁺VEGFR-2⁺ and CD133⁺VEGFR-2⁺ progenitor cells increase during normal pregnancy but are reduced in women with preeclampsia Reprod Sci 2010 Jul 17 7 643 52 10.1177/1933719110366164 Open DOISearch in Google Scholar

9. Gussin HA, Bischoff FZ, Hoffman R, Elias S. Endothelial precursor cells in the peripheral blood of pregnant women. J Soc Gynecol Investig. 2002 Nov–Dec;9(6):357–61. doi: 10.1016/s1071-5576(02)00188-0 GussinHA BischoffFZ HoffmanR EliasS Endothelial precursor cells in the peripheral blood of pregnant women J Soc Gynecol Investig 2002 Nov–Dec 9 6 357 61 10.1016/s1071-5576(02)00188-0 Open DOISearch in Google Scholar

10. Sugawara J, Mitsui-Saito M, Hoshiai T, Hayashi C, Kimura Y, Okamura K. Circulating endothelial progenitor cells during human pregnancy. J Clin Endocrinol Metab. 2005 Mar;90(3):1845–8. doi: 10.1210/jc.2004-0541 SugawaraJ Mitsui-SaitoM HoshiaiT HayashiC KimuraY OkamuraK Circulating endothelial progenitor cells during human pregnancy J Clin Endocrinol Metab 2005 Mar 90 3 1845 8 10.1210/jc.2004-0541 Open DOISearch in Google Scholar

11. Van Craenenbroeck EM, Van Craenenbroeck AH, van Ierssel S, Bruyndonckx L, Hoymans VY, Vrints CJ, et al. Quantification of circulating CD34⁺/KDR⁺/CD45^dim endothelial progenitor cells: analytical considerations. Int J Cardiol. 2013 Sep 1;167(5):1688–95. doi: 10.1016/j.ijcard.2012.10.047 Van CraenenbroeckEM Van CraenenbroeckAH van IersselS BruyndonckxL HoymansVY VrintsCJ Quantification of circulating CD34⁺/KDR⁺/CD45^dim endothelial progenitor cells: analytical considerations Int J Cardiol. 2013 Sep 1 167 5 1688 95 10.1016/j.ijcard.2012.10.047 Open DOISearch in Google Scholar

12. Melamed N, Baschat A, Yinon Y, Athanasiadis A, Mecacci F, Figueras F, et al. FIGO (international Federation of Gynecology and obstetrics) initiative on fetal growth: best practice advice for screening, diagnosis, and management of fetal growth restriction. Int J Gynaecol Obstet. 2021 Mar;152 Suppl 1(Suppl 1): 3–57. doi: 10.1002/ijgo.13522 MelamedN BaschatA YinonY AthanasiadisA MecacciF FiguerasF FIGO (international Federation of Gynecology and obstetrics) initiative on fetal growth: best practice advice for screening, diagnosis, and management of fetal growth restriction Int J Gynaecol Obstet 2021 Mar 152 Suppl 1(Suppl 1) 3 57 10.1002/ijgo.13522 Open DOISearch in Google Scholar

13. Cetin I, Alvino G. Intrauterine growth restriction: implications for placental metabolism and transport. A review. Placenta. 2009 Mar;30 Suppl A:S77–82. doi: 10.1016/j.placenta.2008.12.006 CetinI AlvinoG Intrauterine growth restriction: implications for placental metabolism and transport A review. Placenta 2009 Mar 30 Suppl A S77 82 10.1016/j.placenta.2008.12.006 Open DOISearch in Google Scholar

14. Colombo E, Marconi C, Taddeo A, Cappelletti M, Villa ML, Marzorati M, et al. Fast reduction of peripheral blood endothelial progenitor cells in healthy humans exposed to acute systemic hypoxia. J Physiol. 2012 Feb 1;590(3):519–32. doi: 10.1113/jphysiol.2011.223032 ColomboE MarconiC TaddeoA CappellettiM VillaML MarzoratiM Fast reduction of peripheral blood endothelial progenitor cells in healthy humans exposed to acute systemic hypoxia J Physiol. 2012 Feb 1 590 3 519 32 10.1113/jphysiol.2011.223032 Open DOISearch in Google Scholar

15. Mallucci G, Beneventi F, Bergamaschi R, Bizzotto C, Cavagnoli C, De Maggio I, et al. Circulating endothelial progenitor cells during pregnancy in multiple sclerosis. Neurol Sci. 2021 Apr;42(4): 1443–1451. doi: 10.1007/s10072-020-04648-3 MallucciG BeneventiF BergamaschiR BizzottoC CavagnoliC De MaggioI Circulating endothelial progenitor cells during pregnancy in multiple sclerosis Neurol Sci 2021 Apr 42 4 1443 1451 10.1007/s10072-020-04648-3 Open DOISearch in Google Scholar

16. Mousavi SH, Abroun S, Zarrabi M, Ahmadipanah M. The effect of maternal and infant factors on cord blood yield. Pediatr Blood Cancer. 2017 Jul;64(7):e26381. doi: 10.1002/pbc.26381 MousaviSH AbrounS ZarrabiM AhmadipanahM The effect of maternal and infant factors on cord blood yield Pediatr Blood Cancer 2017 Jul 64 7 e26381 10.1002/pbc.26381 Open DOISearch in Google Scholar

17. Timmermans F, Van Hauwermeiren F, De Smedt M, Raedt R, Plasschaert F, De Buyzere ML, et al. Endothelial outgrowth cells are not derived from CD133⁺ cells or CD45⁺ hematopoietic precursors. Arterioscler Thromb Vasc Biol. 2007 Jul;27(7):1572–9. doi: 10.1161/ATVBAHA.107.144972 TimmermansF Van HauwermeirenF De SmedtM RaedtR PlasschaertF De BuyzereML Endothelial outgrowth cells are not derived from CD133⁺ cells or CD45⁺ hematopoietic precursors Arterioscler Thromb Vasc Biol 2007 Jul 27 7 1572 9 10.1161/ATVBAHA.107.144972 Open DOISearch in Google Scholar

18. Giordano D, Loddo S, Laganà AS, Coppolino G, Zoccali G, Di Benedetto A, et al. Peripheral blood CD34⁺ cells as a novel and noninvasive early marker of first trimester miscarriage: results from a case-control analysis. J Matern Fetal Neonatal Med. 2018 Jan;31(2):258–260. doi: 10.1080/14767058.2016.1277703 GiordanoD LoddoS LaganàAS CoppolinoG ZoccaliG Di BenedettoA Peripheral blood CD34⁺ cells as a novel and noninvasive early marker of first trimester miscarriage: results from a case-control analysis J Matern Fetal Neonatal Med 2018 Jan 31 2 258 260 10.1080/14767058.2016.1277703 Open DOISearch in Google Scholar

19. Li B, Sharpe EE, Maupin AB, Teleron AA, Pyle AL, Carmeliet P, et al. VEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization. FASEB J. 2006; 20:E664–76. LiB SharpeEE MaupinAB TeleronAA PyleAL CarmelietP VEGF and PlGF promote adult vasculogenesis by enhancing EPC recruitment and vessel formation at the site of tumor neovascularization FASEB J. 2006 20 E664 76 Search in Google Scholar

20. Fischer C, Mazzone M, Jonckx B, Carmeliet P. FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy? Nat Rev Cancer. 2008 Dec;8(12):942–56. doi: 10.1038/nrc2524 FischerC MazzoneM JonckxB CarmelietP FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy? Nat Rev Cancer. 2008 Dec 8 12 942 56 10.1038/nrc2524 Open DOISearch in Google Scholar

21. Wallner W, Sengenberger R, Strick R, Strissel PL, Meurer B, Beckmann MW, et al. Angiogenic growth factors in maternal and fetal serum in pregnancies complicated by intrauterine growth restriction. Clin Sci (Lond). 2007 Jan;112(1):51–7. doi: 10.1042/CS20060161 WallnerW SengenbergerR StrickR StrisselPL MeurerB BeckmannMW Angiogenic growth factors in maternal and fetal serum in pregnancies complicated by intrauterine growth restriction Clin Sci (Lond) 2007 Jan 112 1 51 7 10.1042/CS20060161 Open DOISearch in Google Scholar

22. Banks RE, Forbes MA, Searles J, Pappin D, Canas B, Rahman D, et al. Evidence for the existence of a novel pregnancy-associated soluble variant of the vascular endothelial growth factor receptor, Flt-1. Mol Hum Reprod. 1998 Apr;4(4):377–86. doi: 10.1093/molehr/4.4.377 BanksRE ForbesMA SearlesJ PappinD CanasB RahmanD Evidence for the existence of a novel pregnancy-associated soluble variant of the vascular endothelial growth factor receptor, Flt-1 Mol Hum Reprod 1998 Apr 4 4 377 86 10.1093/molehr/4.4.377 Open DOISearch in Google Scholar

23. Benton SJ, Hu Y, Xie F, Kupfer K, Lee SW, Magee LA, et al. Can placental growth factor in maternal circulation identify fetuses with placental intrauterine growth restriction? Am J Obstet Gynecol. 2012 Feb;206(2):163.e1–7. doi: 10.1016/j.ajog.2011.09.019 BentonSJ HuY XieF KupferK LeeSW MageeLA Can placental growth factor in maternal circulation identify fetuses with placental intrauterine growth restriction? Am J Obstet Gynecol. 2012 Feb 206 2 163.e1 7 10.1016/j.ajog.2011.09.019 Open DOISearch in Google Scholar

24. Sipos PI, Bourque SL, Hubel CA, Baker PN, Sibley CP, Davidge ST, et al. Endothelial colony-forming cells derived from pregnancies complicated by intrauterine growth restriction are fewer and have reduced vasculogenic capacity. J Clin Endocrinol Metab. 2013 Dec;98(12):4953–60. doi: 10.1210/jc.2013-2580 SiposPI BourqueSL HubelCA BakerPN SibleyCP DavidgeST Endothelial colony-forming cells derived from pregnancies complicated by intrauterine growth restriction are fewer and have reduced vasculogenic capacity J Clin Endocrinol Metab 2013 Dec 98 12 4953 60 10.1210/jc.2013-2580 Open DOISearch in Google Scholar

25. Yoder MC, Mead LE, Prater D, Krier TR, Mroueh KN, Li F, et al. Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood. 2007 Mar 1;109(5):1801–9. doi: 10.1182/blood-2006-08-043471 YoderMC MeadLE PraterD KrierTR MrouehKN LiF Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals Blood. 2007 Mar 1 109 5 1801 9 10.1182/blood-2006-08-043471 Open DOISearch in Google Scholar

26. King TF, Bergin DA, Kent EM, Manning F, Reeves EP, Dicker P, et al. Endothelial progenitor cells in mothers of low-birthweight infants: a link between defective placental vascularization and increased cardiovascular risk? J Clin Endocrinol Metab. 2013 Jan;98(1):E33–9. doi: 10.1210/jc.2012-2793 KingTF BerginDA KentEM ManningF ReevesEP DickerP Endothelial progenitor cells in mothers of low-birthweight infants: a link between defective placental vascularization and increased cardiovascular risk? J Clin Endocrinol Metab. 2013 Jan 98 1 E33 9 10.1210/jc.2012-2793 Open DOISearch in Google Scholar

27. Monga R, Buck S, Sharma P, Thomas R, Chouthai NS. Effect of preeclampsia and intrauterine growth restriction on endothelial progenitor cells in human umbilical cord blood. J Matern Fetal Neonatal Med. 2012 Nov;25(11):2385–9. doi: 10.3109/14767058.2012.697228 MongaR BuckS SharmaP ThomasR ChouthaiNS Effect of preeclampsia and intrauterine growth restriction on endothelial progenitor cells in human umbilical cord blood J Matern Fetal Neonatal Med 2012 Nov 25 11 2385 9 10.3109/14767058.2012.697228 Open DOISearch in Google Scholar

28. Kumasawa K, Ikawa M, Kidoya H, Hasuwa H, Saito-Fujita T, Morioka Y, et al. Pravastatin induces placental growth factor (PGF) and ameliorates preeclampsia in a mouse model. Proc Natl Acad Sci U S A. 2011 Jan 25;108(4):1451–5. doi: 10.1073/pnas.1011293108 KumasawaK IkawaM KidoyaH HasuwaH Saito-FujitaT MoriokaY Pravastatin induces placental growth factor (PGF) and ameliorates preeclampsia in a mouse model Proc Natl Acad Sci U S A. 2011 Jan 25 108 4 1451 5 10.1073/pnas.1011293108 Open DOISearch in Google Scholar

29. Chang JC, Chen YJ, Chen IC, Lin WS, Chen YM, Lin CH. Perinatal Outcomes After Statin Exposure During Pregnancy. JAMA Netw Open. 2021 Dec 1;4(12):e2141321. doi: 10.1001/jamanetworkopen.2021.41321 ChangJC ChenYJ ChenIC LinWS ChenYM LinCH Perinatal Outcomes After Statin Exposure During Pregnancy JAMA Netw Open. 2021 Dec 1 4 12 e2141321 10.1001/jamanetworkopen.2021.41321 Open DOISearch in Google Scholar